Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Advances in the medical treatment of Cushing's syndrome.

Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A.

Lancet Diabetes Endocrinol. 2018 Jul 19. pii: S2213-8587(18)30155-4. doi: 10.1016/S2213-8587(18)30155-4. [Epub ahead of print] Review.

PMID:
30033041
2.

Recent Updates on the Diagnosis and Management of Cushing's Syndrome.

Nieman LK.

Endocrinol Metab (Seoul). 2018 Jun;33(2):139-146. doi: 10.3803/EnM.2018.33.2.139. Review.

3.

Diverticular Perforation: A Fatal Complication to Forestall in Cushing Syndrome.

Sater ZA, Jha S, McGlotten R, Hartley I, El Lakis M, Araque KA, Nieman LK.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2811-2814. doi: 10.1210/jc.2018-00829.

PMID:
29846662
4.

Diagnosis of Cushing's Syndrome in the Modern Era.

Nieman LK.

Endocrinol Metab Clin North Am. 2018 Jun;47(2):259-273. doi: 10.1016/j.ecl.2018.02.001. Review.

PMID:
29754631
5.

Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals.

Muniyappa R, Noureldin RA, Abd-Elmoniem KZ, El Khouli RH, Matta JR, Hamimi A, Ranganath S, Hadigan C, Nieman LK, Gharib AM.

Cardiorenal Med. 2018;8(2):140-150. doi: 10.1159/000487205. Epub 2018 Mar 26.

PMID:
29617001
6.

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback.

Nguyen TV, Reuter JM, Gaikwad NW, Rotroff DM, Kucera HR, Motsinger-Reif A, Smith CP, Nieman LK, Rubinow DR, Kaddurah-Daouk R, Schmidt PJ.

Transl Psychiatry. 2017 Aug 8;7(8):e1193. doi: 10.1038/tp.2017.146.

7.

Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.

Schmidt PJ, Martinez PE, Nieman LK, Koziol DE, Thompson KD, Schenkel L, Wakim PG, Rubinow DR.

Am J Psychiatry. 2017 Oct 1;174(10):980-989. doi: 10.1176/appi.ajp.2017.16101113. Epub 2017 Apr 21.

PMID:
28427285
8.

The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.

Dubey N, Hoffman JF, Schuebel K, Yuan Q, Martinez PE, Nieman LK, Rubinow DR, Schmidt PJ, Goldman D.

Mol Psychiatry. 2017 Aug;22(8):1172-1184. doi: 10.1038/mp.2016.229. Epub 2017 Jan 3.

9.

Thymic Hyperplasia after Treatment of ACTH-Dependent Cushing's Syndrome Can Be Mistaken for a Thymic Epithelial Tumor.

Del Rivero J, Kim C, Eid M, Ahlman MA, Nieman LK, Rajan A.

J Thorac Oncol. 2017 Apr;12(4):e29-e32. doi: 10.1016/j.jtho.2016.11.2215. Epub 2016 Nov 16. No abstract available.

10.

Endometrial Effects of Prolonged Therapy with the Selective Progesterone Receptor Modulator Ulipristal Acetate: A Case Report.

Levy G, Elkas J, Armstrong AY, Nieman LK.

J Reprod Med. 2016 Mar-Apr;61(3-4):159-62.

PMID:
27172639
11.

Cosyntropin-Stimulated Serum Free Cortisol in Healthy, Adrenally Insufficient, and Mildly Cirrhotic Populations.

Rauschecker M, Abraham SB, Abel BS, Wesley R, Saverino E, Trivedi A, Heller T, Nieman LK.

J Clin Endocrinol Metab. 2016 Mar;101(3):1075-81. doi: 10.1210/jc.2015-2285. Epub 2015 Dec 8.

12.

5╬▒-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ.

Neuropsychopharmacology. 2016 Mar;41(4):1093-102. doi: 10.1038/npp.2015.246. Epub 2013 Aug 14.

13.

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society.

J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.

14.

Cushing's syndrome: update on signs, symptoms and biochemical screening.

Nieman LK.

Eur J Endocrinol. 2015 Oct;173(4):M33-8. doi: 10.1530/EJE-15-0464. Epub 2015 Jul 8. Review.

15.

Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.

Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR.

JAMA Psychiatry. 2015 Jul;72(7):714-26. doi: 10.1001/jamapsychiatry.2015.0111.

PMID:
26018333
16.

Cushing's syndrome.

Lacroix A, Feelders RA, Stratakis CA, Nieman LK.

Lancet. 2015 Aug 29;386(9996):913-27. doi: 10.1016/S0140-6736(14)61375-1. Epub 2015 May 21. Review.

PMID:
26004339
17.

Cushing's syndrome: epidemiology and developments in disease management.

Sharma ST, Nieman LK, Feelders RA.

Clin Epidemiol. 2015 Apr 17;7:281-93. doi: 10.2147/CLEP.S44336. eCollection 2015. Review.

18.

Update on subclinical Cushing's syndrome.

Nieman LK.

Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):180-4. doi: 10.1097/MED.0000000000000159. Review.

PMID:
25887388
19.

Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.

Mehta GU, Montgomery BK, Raghavan P, Sharma S, Nieman LK, Patronas N, Oldfield EH, Chittiboina P.

J Clin Neurosci. 2015 May;22(5):891-4. doi: 10.1016/j.jocn.2015.01.001. Epub 2015 Mar 29.

20.

Comorbidities in Cushing's disease.

Sharma ST, Nieman LK, Feelders RA.

Pituitary. 2015 Apr;18(2):188-94. doi: 10.1007/s11102-015-0645-6. Review.

Supplemental Content

Loading ...
Support Center